166 related articles for article (PubMed ID: 36913648)
21. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
[TBL] [Abstract][Full Text] [Related]
22. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.
Carpenter JM; Criddle CA; Craig HK; Ali Z; Zhang Z; Khan IA; Sufka KJ
Fitoterapia; 2016 Mar; 109():87-90. PubMed ID: 26688378
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain.
Ramachandram DS; Damodaran T; Zainal H; Murugaiyah V; Ramanathan S
J Basic Clin Physiol Pharmacol; 2019 Oct; 31(1):. PubMed ID: 31665120
[TBL] [Abstract][Full Text] [Related]
25. Identification and Characterization of Indole and Oxindole Alkaloids from Leaves of Mitragyna speciosa Korth Using Liquid Chromatography-Accurate QToF Mass Spectrometry.
Avula B; Sagi S; Wang YH; Wang M; Ali Z; Smillie TJ; Zweigenbaum J; Khan IA
J AOAC Int; 2015; 98(1):13-21. PubMed ID: 25857873
[TBL] [Abstract][Full Text] [Related]
26. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
[TBL] [Abstract][Full Text] [Related]
27. The Chemistry of Kratom [
Flores-Bocanegra L; Raja HA; Graf TN; Augustinović M; Wallace ED; Hematian S; Kellogg JJ; Todd DA; Cech NB; Oberlies NH
J Nat Prod; 2020 Jul; 83(7):2165-2177. PubMed ID: 32597657
[TBL] [Abstract][Full Text] [Related]
28. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method.
Berthold EC; Kamble SH; Raju KS; King TI; Popa R; Sharma A; León F; Avery BA; McMahon LR; McCurdy CR
J Pharm Biomed Anal; 2021 Feb; 194():113778. PubMed ID: 33277117
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
30. Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (
Ya K; Methaneethorn J; Tran QB; Trakulsrichai S; Wananukul W; Lohitnavy M
J Psychoactive Drugs; 2021; 53(2):127-139. PubMed ID: 34003732
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric Total Syntheses of Mitragynine, Speciogynine, and 7-Hydroxymitragynine.
Sakamoto J; Kitajima M; Ishikawa H
Chem Pharm Bull (Tokyo); 2022; 70(9):662-668. PubMed ID: 36047237
[TBL] [Abstract][Full Text] [Related]
32. Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum.
Horie S; Koyama F; Takayama H; Ishikawa H; Aimi N; Ponglux D; Matsumoto K; Murayama T
Planta Med; 2005 Mar; 71(3):231-6. PubMed ID: 15770543
[TBL] [Abstract][Full Text] [Related]
33. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
34. The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell.
Jamil MF; Subki MF; Lan TM; Majid MI; Adenan MI
J Ethnopharmacol; 2013 Jun; 148(1):135-43. PubMed ID: 23608241
[TBL] [Abstract][Full Text] [Related]
35. Directed Biosynthesis of Mitragynine Stereoisomers.
Schotte C; Jiang Y; Grzech D; Dang TT; Laforest LC; León F; Mottinelli M; Nadakuduti SS; McCurdy CR; O'Connor SE
J Am Chem Soc; 2023 Mar; 145(9):4957-4963. PubMed ID: 36883326
[No Abstract] [Full Text] [Related]
36. The effects of chronic mitragynine (Kratom) exposure on the EEG in rats.
Suhaimi FW; Hassan Z; Mansor SM; Müller CP
Neurosci Lett; 2021 Feb; 745():135632. PubMed ID: 33444671
[TBL] [Abstract][Full Text] [Related]
37. Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats.
Sabetghadam A; Ramanathan S; Sasidharan S; Mansor SM
J Ethnopharmacol; 2013 Apr; 146(3):815-23. PubMed ID: 23422336
[TBL] [Abstract][Full Text] [Related]
38. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
39. Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats.
Hassan R; Othman N; Mansor SM; Müller CP; Hassan Z
Brain Res Bull; 2021 Jul; 172():139-150. PubMed ID: 33901587
[TBL] [Abstract][Full Text] [Related]
40. Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves.
Veeramohan R; Zamani AI; Azizan KA; Goh HH; Aizat WM; Razak MFA; Yusof NSM; Mansor SM; Baharum SN; Ng CL
PLoS One; 2023; 18(3):e0283147. PubMed ID: 36943850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
